Renhe Pharmacy Co Ltd (000650) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Renhe Pharmacy Co Ltd (000650) has a cash flow conversion efficiency ratio of 0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥188.23 Million ≈ $27.54 Million USD) by net assets (CN¥7.04 Billion ≈ $1.03 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000650 equity financing ratio to measure how much of total assets are equity-financed.
Renhe Pharmacy Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Renhe Pharmacy Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Renhe Pharmacy Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Renhe Pharmacy Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Renhe Pharmacy Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
0.285x |
|
China Harzone Industry Corp Ltd
SHE:300527
|
0.010x |
|
Bukit Uluwatu Villa Tbk
JK:BUVA
|
0.023x |
|
Guangzhou Goaland Energy Conservation Tech Co Ltd
SHE:300499
|
0.026x |
|
Certara Inc
NASDAQ:CERT
|
0.027x |
|
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
|
-0.043x |
|
EmbedWay Tech(Shanghai)Corp
SHG:603496
|
0.038x |
|
Jiangsu Zhengdan Chemical Industry Co Ltd
SHE:300641
|
0.039x |
Annual Cash Flow Conversion Efficiency for Renhe Pharmacy Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Renhe Pharmacy Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Renhe Pharmacy Co Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.93 Billion ≈ $1.01 Billion |
CN¥851.31 Million ≈ $124.57 Million |
0.123x | +49.99% |
| 2024-12-31 | CN¥6.81 Billion ≈ $995.93 Million |
CN¥557.26 Million ≈ $81.54 Million |
0.082x | +9.09% |
| 2023-12-31 | CN¥6.65 Billion ≈ $973.76 Million |
CN¥499.47 Million ≈ $73.09 Million |
0.075x | -62.05% |
| 2022-12-31 | CN¥6.42 Billion ≈ $939.71 Million |
CN¥1.27 Billion ≈ $185.84 Million |
0.198x | +50.71% |
| 2021-12-31 | CN¥5.93 Billion ≈ $867.29 Million |
CN¥777.72 Million ≈ $113.80 Million |
0.131x | -15.49% |
| 2020-12-31 | CN¥5.61 Billion ≈ $820.99 Million |
CN¥871.13 Million ≈ $127.47 Million |
0.155x | -2.63% |
| 2019-12-31 | CN¥4.35 Billion ≈ $636.83 Million |
CN¥693.97 Million ≈ $101.55 Million |
0.159x | +9.63% |
| 2018-12-31 | CN¥3.91 Billion ≈ $572.89 Million |
CN¥569.45 Million ≈ $83.33 Million |
0.145x | +1.45% |
| 2017-12-31 | CN¥3.47 Billion ≈ $508.13 Million |
CN¥497.86 Million ≈ $72.85 Million |
0.143x | -12.00% |
| 2016-12-31 | CN¥3.20 Billion ≈ $468.92 Million |
CN¥522.08 Million ≈ $76.40 Million |
0.163x | -2.54% |
| 2015-12-31 | CN¥2.60 Billion ≈ $380.59 Million |
CN¥434.77 Million ≈ $63.62 Million |
0.167x | -1.06% |
| 2014-12-31 | CN¥2.16 Billion ≈ $316.38 Million |
CN¥365.27 Million ≈ $53.45 Million |
0.169x | +53.53% |
| 2013-12-31 | CN¥1.94 Billion ≈ $283.72 Million |
CN¥213.36 Million ≈ $31.22 Million |
0.110x | +2.41% |
| 2012-12-31 | CN¥1.71 Billion ≈ $250.53 Million |
CN¥183.97 Million ≈ $26.92 Million |
0.107x | -26.48% |
| 2011-12-31 | CN¥1.14 Billion ≈ $167.13 Million |
CN¥166.93 Million ≈ $24.43 Million |
0.146x | +2.48% |
| 2010-12-31 | CN¥912.05 Million ≈ $133.46 Million |
CN¥130.07 Million ≈ $19.03 Million |
0.143x | -39.05% |
| 2009-12-31 | CN¥857.16 Million ≈ $125.43 Million |
CN¥200.58 Million ≈ $29.35 Million |
0.234x | +15.08% |
| 2008-12-31 | CN¥305.60 Million ≈ $44.72 Million |
CN¥62.14 Million ≈ $9.09 Million |
0.203x | +35.25% |
| 2007-12-31 | CN¥235.44 Million ≈ $34.45 Million |
CN¥35.40 Million ≈ $5.18 Million |
0.150x | -87.56% |
| 2006-12-31 | CN¥194.71 Million ≈ $28.49 Million |
CN¥235.28 Million ≈ $34.43 Million |
1.208x | +421.39% |
| 2005-12-31 | CN¥46.88 Million ≈ $6.86 Million |
CN¥-17.63 Million ≈ $-2.58 Million |
-0.376x | -462.08% |
| 2004-12-31 | CN¥169.04 Million ≈ $24.74 Million |
CN¥17.55 Million ≈ $2.57 Million |
0.104x | +149.33% |
| 2003-12-31 | CN¥238.17 Million ≈ $34.85 Million |
CN¥-50.14 Million ≈ $-7.34 Million |
-0.211x | -354.75% |
| 2002-12-31 | CN¥338.74 Million ≈ $49.57 Million |
CN¥27.99 Million ≈ $4.10 Million |
0.083x | +702.09% |
| 2001-12-31 | CN¥331.58 Million ≈ $48.52 Million |
CN¥3.42 Million ≈ $499.90K |
0.010x | +109.60% |
| 2000-12-31 | CN¥345.32 Million ≈ $50.53 Million |
CN¥-37.08 Million ≈ $-5.43 Million |
-0.107x | -141.68% |
| 1999-12-31 | CN¥261.49 Million ≈ $38.26 Million |
CN¥67.37 Million ≈ $9.86 Million |
0.258x | +316.08% |
| 1998-12-31 | CN¥233.76 Million ≈ $34.21 Million |
CN¥14.48 Million ≈ $2.12 Million |
0.062x | -- |
About Renhe Pharmacy Co Ltd
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more